Analyst picks & changes

Genentech Inc.

S.G. Warburg analyst Kevin Wilson downgraded Genentech Inc. to "add" from "buy" on the basis of valuation. Wilson said the South San Francisco company's

Read the full 252 word article

How to gain access

Continue reading with a
two-week free trial.